Hera Womens Health Delivering better obstetrical outcomes 💓 Obstetric emergencies and adverse maternalperinatal outcomes

Cardiovascular Evaluation and Considerations for Women of

Hera Biotech bags $19M for endometriosis diagnostic test

Hera Women's Health Company Profile Valuation Funding

Comparison of Midwifery and Obstetric Care in LowRisk

Risk of Adverse Maternal Outcomes in Pregnant Women With

Hera Womens Health Delivering better obstetrical outcomes

Maternal outcomes and birth interventions among women who

Hera Womens Health Delivering better obstetrical outcomes

Obstetrical outcomes and maternal morbidities associated with

Hera Crunchbase Company Profile Funding

Maternal hemorrhage in 2024 Is your team ready

Hera Funding Financials Valuation Investors Crunchbase

Obstetric emergencies and adverse maternalperinatal outcomes


24 août 2024 · August 24, 2024. 3 minutes. Photo/Shutterstock. San Antonio-based medical device start-up Hera Biotech has closed an oversubscribed $1.9 million seed financing round to support its commercialization strategy for its non-surgical diagnostic test for endometriosis, MetriDx. 30 nov. 2024 · Maternal morbidities and adverse obstetrical outcomes among those with or without COVID-19 were analyzed with a multivariable logistic regression model adjusted on patient characteristics. Among pregnant women, older age (31.1 (±5.9) years old versus 30.5 (±5.4) years old, respectively, p < 0.001), obesity (0.7% versus 0.3%. 30 nov. 2024 · Our study aimed to address the question of whether COVID-19 is associated with risk of adverse obstetrical outcomes among pregnant women by comparing 2 groups of pregnant women with or without COVID-19 during the first wave of the COVID-19 pandemic. 30 nov. 2024 · Maternal morbidities and adverse obstetrical outcomes with or without COVID-19 were analyzed with a model adjusted on patient characteristics that could be risk factors: maternal age, body mass index, active smoking, parity, history of diabetes or hypertension, multiple pregnancy, and assisted reproductive technique (ART) conception. 30 nov. 2024 · Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study November 2024 PLoS Medicine 18(11):e1003857. 1 nov. 2024 · An increased frequency of pregnant women with maternal morbidities and adverse obstetrical outcomes among those with or without COVID-19 was observed and Frequency of ART conception was not different between those with and without CO VID-19 diagnosis. Expand. [PDF] Semantic Reader. 5 déc. 2024 · To answer this question, the researchers behind the current study aimed to determine whether maternal morbidities and adverse obstetrical outcomes were more frequent in pregnant women with.